Related Experiment Video

Updated: May 31, 2026

Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo
07:19

Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo

Published on: August 4, 2021

Switching on the lights: the use of optogenetics to advance retinal gene therapy

Therese Cronin1, Jean Bennett

  • 1FM Kirby Center for Molecular Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. theresec@mail.med.upenn.edu

Molecular Therapy : the Journal of the American Society of Gene Therapy
|July 2, 2011
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

In vivo Optogenetic Stimulation of the Rodent Central Nervous System
09:37

In vivo Optogenetic Stimulation of the Rodent Central Nervous System

Published on: January 15, 2015

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

Related Experiment Videos

Last Updated: May 31, 2026

Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo
07:19

Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo

Published on: August 4, 2021

In vivo Optogenetic Stimulation of the Rodent Central Nervous System
09:37

In vivo Optogenetic Stimulation of the Rodent Central Nervous System

Published on: January 15, 2015

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

Articles linked to this work by shared authors, journal, and citation graph.

Clinically relevant AAV8- PEX1 gene therapy preserves retinal integrity and function long-term in a murine model of Zellweger spectrum disorder.

bioRxiv : the preprint server for biology·2026

Combined Expression of hRdCVF and hRdCVFL Through AAV-Mediated Delivery for the Treatment of Retinitis Pigmentosa.

Investigative ophthalmology & visual science·2026

Retinal Impairments in Mice Lacking Both Nxnl1 and Nxnl2 Genes.

Investigative ophthalmology & visual science·2025

Recovery of cone-mediated vision in Lebercilin associated retinal ciliopathy after gene therapy: One-year results of a phase I/II trial.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Generation of a compound heterozygous ABCA4 rat model with pathological features of STGD1.

Human molecular genetics·2025

High-efficiency base editing in the retina in primates and human tissues.

Nature medicine·2025

Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Targeting white matter astrocytes with a Gfap-disruptive Cas9 nuclease benefits a murine model of Alexander disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Multiplexed genome editing by CRISPR-Un1Cas12f1 restores dystrophin expression in a mouse model of Duchenne muscular dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

A phase 1/2 dose-escalation study of sepiapterin in patients with 6-pyruvoyl-tetrahydropterin synthase deficiency with hyperphenylalaninemia.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

D-Amino Acid Prodrug DLMEH Activates mTORC1 via Sestrin2 to Restore Muscle Protein Synthesis in Sarcopenia.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Combination Of Bispecific Antibodies Enable Targeted TNFRSF Agonism and Effective Antitumor Activity.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Polarization dependent Raman scattering in WS2: revealing anisotropic Fano resonance involving acoustic phonons.

Physical chemistry chemical physics : PCCP·2026

Intermolecular Hydrogen Bonds Inducing Paramagnetism for Nondestructive CEST Imaging of Nitric Oxide.

Advanced materials (Deerfield Beach, Fla.)·2026

Dual-mode colorimetric and photothermal sensing platform for point-of-care testing of uric acid based on enhanced peroxidase-like activity of platinum-based nanozyme by adenosine triphosphate.

Analytica chimica acta·2026

Visualized self-propelled nanorobots overcome tumor barriers for boosted photothermal-nanocatalytic synergistic therapy against triple-negative breast cancer.

Journal of nanobiotechnology·2026

A PSA4-YCF4 complex promotes assembly of the photosystem I reaction center in Arabidopsis.

The Plant cell·2026

Bidirectional optoelectronic switching in protein by photoinduced phase transition.

Science advances·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us